NYSE:BHVN
Biohaven Ltd.
Biohaven Ltd. reported net income of −$738.8M in fiscal 2025. Free cash flow was −$610.2M, and the diluted share count rose 18.0%.Summary generated from Biohaven Ltd.'s SEC filings. Latest annual report filed Mar 2, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−310.8%
Debt / equityn/a
Free cash flow−$610.2M
FCF marginn/a
Share count change+18.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating income | −219 | −568 | −436 | −885 | −745 |
| Net income | −214 | −570 | −408 | −846 | −739 |
| Free cash flow | −147 | −304 | −335 | −587 | −610 |
Recent filings
- 4Insider transaction report
Sep 17, 2026 - 8-KOther events
Sep 10, 2026 - 8-KEntry into a material agreement
Aug 26, 2026 - 8-KResults of operations and financial condition
Aug 10, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 10, 2026 - 8-KDirector or officer change
Aug 7, 2026 - 8-KDirector or officer change
Jul 9, 2026 - 8-KRegulation FD disclosure
May 27, 2026